Sabra Health Care REIT, Inc.

Sabra Health Care REIT, Inc. has seen notable stock performance, with significant gains over various timeframes, including a 21.63% rise in the past month. The company maintains a high dividend yield and strong institutional support, while its market capitalization stands at approximately USD 4.95 billion.

Sabra Health Care REIT, Inc. has achieved a new 52-week high, reflecting strong performance in the realty sector, particularly among small-cap companies. Over the past year, it has shown notable growth, significantly outperforming the S&P 500, while maintaining a high dividend yield and solid financial ratios.

Sabra Health Care REIT, Inc. has recently revised its evaluation amid current market conditions. The stock price has seen a slight increase, with a year-to-date return of 9.08%, outperforming the S&P 500. Over three years, Sabra has demonstrated strong resilience, achieving a return of 77.34%.

Sabra Health Care REIT, Inc. has recently revised its evaluation amid changing market conditions. The company’s stock price is currently $20.24, with a notable year-to-date return of 6.86%. Over three years, Sabra has achieved an impressive return of 89.34%, outperforming the S&P 500.

Sabra Health Care REIT, Inc. has recently seen a slight decline in stock price, yet it has achieved a 22.30% return over the past year, surpassing the S&P 500's 20.12%. Technical indicators present a mixed outlook, reflecting both bullish and bearish signals in the market.

Sabra Health Care REIT, Inc. has recently revised its evaluation amid current market dynamics. The stock is priced at $20.02, with a 17.14% return over the past year, trailing the S&P 500. Technical indicators show mixed signals, reflecting the complexities of its market position.

Sabra Health Care REIT, Inc. has achieved a new 52-week high, reflecting strong performance in the realty sector, particularly among small-cap companies. Over the past year, it has shown impressive growth, significantly outperforming the S&P 500, and offers a notable dividend yield, enhancing its appeal to investors.

Sabra Health Care REIT, Inc. achieved a new 52-week high of USD 20.88, reflecting a strong performance with a 48.26% increase over the past year. The company, with a market cap of USD 5,025 million, has a P/E ratio of 24.00 and a notable dividend yield of 552.13%.

Sabra Health Care REIT, Inc. has recently revised its evaluation amid changing market conditions. Currently priced at $18.83, the company has seen a 2.11% return over the past year, significantly lower than the S&P 500. Its performance over three years stands at 47.57%, trailing the index's 81.77% return.